Preventing Downtime in Biotech – A Proactive Approach to Network Performance
In biotech, downtime isn’t just inconvenient, it’s a strategic risk. A few hours of network failure can delay critical research, interfere with compliance logs, and even compromise clinical trials. For C-level executives navigating complex projects, tight regulatory windows, and innovation pipelines, ensuring continuous network performance must be a top operational priority. The good news? Most […]